NCT04299958

Brief Summary

Observational analytic study with prospective cohort design that aim to describe the presence of typical features of migraine in a cohort of nummular headache patients. The aim of the study is to analyze family history, epidemiology, clinical description, presence of prodromes, postdromes and response to treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 9, 2020

Completed
23 days until next milestone

Study Start

First participant enrolled

April 1, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2023

Completed
Last Updated

September 22, 2023

Status Verified

September 1, 2023

Enrollment Period

3 years

First QC Date

March 5, 2020

Last Update Submit

September 21, 2023

Conditions

Keywords

Nummular headache

Outcome Measures

Primary Outcomes (9)

  • Family history of migraine

    To assess family history of migraine headache in nummular patients. We will build family tree up to 3 generations and we will ask patients to complete it by questioning their relatives.

    Through study completion, an average of 1 month

  • Epidemiological pattern

    To determine age of onset, age when they were diagnosed, temporal pattern and frequency of headache.

    Through study completion, an average of 1 month

  • Clinical phenotype

    To assess the clinical characteristics of nummular headache, analyzing the presence of typical features of migraine. Patients will complete a prospective headache diary for 15 days.

    Through study completion, an average of 1 month

  • Presence of associated symptoms

    To assess the presence of symptoms such as nausea, vomiting, dizziness during the headache episodes.

    Through study completion, an average of 1 month

  • Presence of prodromes

    To assess the presence of typical migraine prodromes before the headache episodes.

    Through study completion, an average of 1 month

  • Presence of postdromes

    To assess the presence of typical migraine postdromes after the headache episode.

    Through study completion, an average of 1 month

  • Presence of sensory disturbances

    To evaluate the presence of sensory changes such as hypoesthesia, hyperalgesia or allodinia upon examination.

    Through study completion, an average of 1 month

  • Response to acute treatment

    To describe response to prior acute medications.

    Through study completion, an average of 1 month

  • Response to prophylactic treatment

    To assess response to prior prophylactic treatments.

    Through study completion, an average of 1 month

Interventions

In the first visit they will be examined by a neurologist with experience in headache disorders and NH diagnosis will be reviewed. Patients will be invited to participate into the study and they will provide and sign informed consent form. They will be instructed and trained to complete the prospective headache diary during 14 days. A follow up visit will be done within 15 to 30 days to review the data and analyze possible sources of bias.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with definite diagnosis of nummular headache that visit the headache outpatient clinic of Valladolid University Hospital.

You may qualify if:

  • Diagnosis of Nummular Headache (NH) according to the International Classification of Headache Disorders, 3rd version (ICHD-3).
  • More than 3 months of NH evolution.
  • No better accounted for by another ICHD-3 diagnosis.
  • Older than 18 years.
  • Capable of prospectively register headache characteristics in a diary.
  • Ability to provide informed consent form.

You may not qualify if:

  • Other primary or secondary headache, except for infrequent tension-type headache or medication overuse headache.
  • Major psychiatric disorders.
  • Alcoholism or drug use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universitario Valladolid

Valladolid, 47003, Spain

Location

Related Publications (5)

  • Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. No abstract available.

    PMID: 29368949BACKGROUND
  • Pareja JA, Caminero AB, Serra J, Barriga FJ, Baron M, Dobato JL, Vela L, Sanchez del Rio M. Numular headache: a coin-shaped cephalgia. Neurology. 2002 Jun 11;58(11):1678-9. doi: 10.1212/wnl.58.11.1678.

    PMID: 12058099BACKGROUND
  • Trigo J, Garcia-Azorin D, Martinez Pias E, Sierra A, Chavarria A, Guerrero AL. Clinical characteristics of nummular headache and differentiation between spontaneous and posttraumatic variant: an observational study. J Headache Pain. 2019 Apr 8;20(1):34. doi: 10.1186/s10194-019-0981-4.

    PMID: 30961529BACKGROUND
  • Garcia-Azorin D, Trigo-Lopez J, Sierra A, Blanco-Garcia L, Martinez-Pias E, Martinez B, Talavera B, Guerrero AL. Observational, open-label, non-randomized study on the efficacy of onabotulinumtoxinA in the treatment of nummular headache: The pre-numabot study. Cephalalgia. 2019 Dec;39(14):1818-1826. doi: 10.1177/0333102419863023. Epub 2019 Jul 4.

    PMID: 31272194BACKGROUND
  • Cuadrado ML, Lopez-Ruiz P, Guerrero AL. Nummular headache: an update and future prospects. Expert Rev Neurother. 2018 Jan;18(1):9-19. doi: 10.1080/14737175.2018.1401925. Epub 2017 Nov 9.

    PMID: 29103335BACKGROUND

MeSH Terms

Conditions

Migraine DisordersHeadache Disorders, Primary

Condition Hierarchy (Ancestors)

Headache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 5, 2020

First Posted

March 9, 2020

Study Start

April 1, 2020

Primary Completion

March 25, 2023

Study Completion

April 25, 2023

Last Updated

September 22, 2023

Record last verified: 2023-09

Locations